Prevalence of Low FIB‐4 in MASLD‐Related Hepatocellular Carcinoma: A Multicentre Study

Darren Jun Hao Tan; Nobuharu Tamaki; Beom Kyung Kim; Karn Wijarnpreecha; Majd B. Aboona; Claire Faulkner; Charlotte Kench; Shirin Salimi; Abdul‐Hamid Sabih; Wen Hui Lim; Pojsakorn Danpanichkul; Benjamin Tay; Y. Teh; John Mok; Benjamin Nah; Cheng Han Ng; Mark Muthiah; Anand V. Kulkarni; Sung Won Lee; Ken Liu; Rohit S. Loomba; Daniel Q. Huang

doi:10.1111/apt.18346

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

More than a quarter of those with MASLD-related HCC without cirrhosis have a low FIB-4. The proposed clinical care pathways may not identify these people for further evaluation.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Tan et al. (2024) studied this question.

synapsesocial.com/papers/69dcc93ba5c75be4cfe54707 https://doi.org/10.1111/apt.18346

View Full Paper

Ask AI

Bookmark

Share

Prevalence of Low FIB‐4 in MASLD‐Related Hepatocellular Carcinoma: A Multicentre Study

Ask about this paper

Abstract

Discussion

Cite This Study

Prevalence of Low FIB‐4 in MASLD‐Related Hepatocellular Carcinoma: A Multicentre Study

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading